Article
The fitness cost of metallo-β-lactamase expression is a potential target for new therapeutic approaches to carbapenem resistance
2023-12-22
Abstract excerpt
<title>Abstract</title> <p>Carbapenem antibiotics represent the most reliable last-resort treatment for bacterial infections. The widespread acquisition of metallo-β-lactamases (MBLs), such as VIM-2, is a significant contributor to the emergence of carbapenem-resistant pathogens. The absence of clinically available MBL inhibitors necessitates the development of new approaches to treat carbapenem-resistant infecti...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5f92d4a3-4257-54ea-bdfe-dbe0cf964c66
- DOI
- 10.21203/rs.3.rs-3683698/v1
